MIPD: Molecules, Imagings, and Clinical Phenotype Integrated Database
- PMID: 40257906
- PMCID: PMC12010968
- DOI: 10.1093/database/baaf029
MIPD: Molecules, Imagings, and Clinical Phenotype Integrated Database
Abstract
Due to tumor heterogeneity, a subset of patients fails to benefit from current treatment strategies. However, an integrated analysis of imaging features, genetic molecules, and clinical phenotypes can characterize tumor heterogeneity, enabling the development of more personalized treatment approaches. Despite its potential, cross-modal databases remain underexplored. To address this gap, we established a comprehensive database encompassing 9965 genes, 5449 proteins, 1121 metabolites, 283 pathways, 854 imaging features, and 73 clinical factors from colorectal cancer patients. This database identifies significantly distinct molecules and imaging features associated with clinical phenotypes and provides survival analysis based on these features. Additionally, it offers genetic molecule annotations, comparative expression levels between tumor and normal tissues, imaging features linked to genetic molecules, and imaging-based models for predicting gene expression levels. Furthermore, the database highlights correlations between genetic molecules, clinical factors, and imaging features. In summary, we present MIPD (Molecules, Imaging, and Clinical Phenotype Correlation Database), a user-friendly, interactive, and specialized platform accessible at http://corgenerf.com. MIPD facilitates the interpretability of cross-modal data by providing query, browse, search, visualization, and download functionalities, thereby offering a valuable resource for advancing precision medicine in colorectal cancer. Database URL: http://corgenerf.
© The Author(s) 2025. Published by Oxford University Press.
Conflict of interest statement
We declared no conflict of interest.
Figures



Similar articles
-
Advancing clinical genomics and precision medicine with GVViZ: FAIR bioinformatics platform for variable gene-disease annotation, visualization, and expression analysis.Hum Genomics. 2021 Jun 26;15(1):37. doi: 10.1186/s40246-021-00336-1. Hum Genomics. 2021. PMID: 34174938 Free PMC article.
-
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues.Genes (Basel). 2019 Feb 22;10(2):171. doi: 10.3390/genes10020171. Genes (Basel). 2019. PMID: 30813377 Free PMC article.
-
ISTransbase: an online database for inhibitor and substrate of drug transporters.Database (Oxford). 2024 Jun 29;2024:baae053. doi: 10.1093/database/baae053. Database (Oxford). 2024. PMID: 38943608 Free PMC article.
-
Integration of genetic variants and gene network for drug repurposing in colorectal cancer.Pharmacol Res. 2020 Nov;161:105203. doi: 10.1016/j.phrs.2020.105203. Epub 2020 Sep 17. Pharmacol Res. 2020. PMID: 32950641
-
HCMMD: systematic evaluation of metabolites in body fluids as liquid biopsy biomarker for human cancers.Aging (Albany NY). 2024 Apr 26;16(8):7487-7504. doi: 10.18632/aging.205779. Epub 2024 Apr 26. Aging (Albany NY). 2024. PMID: 38683118 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2020. CA Cancer J Clin 2020;70:7–30. - PubMed
MeSH terms
Grants and funding
- 24WSXT083/Health Commission of Sichuan Province
- 2024JDHJ0039/Science and Technology Department of Sichuan Province
- 2024ZD0520500 2024ZD0520505/National Key Research and Development Program of China
- 24WSXT083/Health Commission of Sichuan Province
- 2024JDHJ0039/Science and Technology Department of Sichuan Province
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous